NPFCX
Price
$60.86
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
SCMGX
Price
$30.95
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

NPFCX vs SCMGX

Header iconNPFCX vs SCMGX Comparison
Open Charts NPFCX vs SCMGXBanner chart's image
American Funds New Perspective C
Price$60.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Sands Capital Global Growth Inst
Price$30.95
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NPFCX vs SCMGX Comparison Chart
Loading...
VS
NPFCX vs. SCMGX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and SCMGX is a Buy.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 142B vs. SCMGX (1.28B). NPFCX pays higher dividends than SCMGX: NPFCX (0.20) vs SCMGX (0.00). NPFCX was incepted earlier than SCMGX: NPFCX (24 years) vs SCMGX (14 years). NPFCX is a more actively managed with annual turnover of: 17.00 vs. SCMGX (15.00). NPFCX has a lower initial minimum investment than SCMGX: NPFCX (250) vs SCMGX (1000000). SCMGX annual gain was more profitable for investors over the last year : 24.43 vs. NPFCX (17.02). NPFCX return over 5 years is better than : 39.24 vs. SCMGX (15.70).
NPFCXSCMGXNPFCX / SCMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years14 years-
Gain YTD13.8416.589210%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets142B1.28B11,120%
Annual Yield % from dividends0.200.00-
Returns for 1 year17.0224.4370%
Returns for 3 years-8.69-35.6524%
Returns for 5 years39.2415.70250%
Returns for 10 years57.9368.5884%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSLR241.811.83
+0.76%
First Solar
BPRN37.23-0.01
-0.03%
Princeton Bancorp
CMBT15.96-0.14
-0.87%
Euronav NV
IVDA1.71-0.02
-1.16%
Iveda Solutions Inc
ENFN8.42-0.31
-3.55%
Enfusion